Stockreport

Sanofi BTK inhibitor successful in mid-stage MS study [Seeking Alpha]

PRINCIPIA BIOPHARMA INC COMMON  (PRNB) 
Last principia biopharma inc common earnings: 11/5 04:01 pm Check Earnings Report
PDF HealthcareSanofi BTK inhibitor successful in mid-stage MS studyApr. 23, 2020 6:41 AM ET|Sanofi (SNY)Douglas W. HouseSanofi (NASDAQ:positive resultsPhase 2b clinical tri [Read more]